Patents by Inventor Navaneeta K. Gorrepati

Navaneeta K. Gorrepati has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9486454
    Abstract: Embodiments of a hydrazaline hydrochloride composition for treatment of hypertension in humans each provide sustained release of hydralazine hydrochloride administered in the form of pellets, granules and tablets. Methods of preparation are disclosed.
    Type: Grant
    Filed: February 12, 2015
    Date of Patent: November 8, 2016
    Inventor: Navaneeta K. Gorrepati
  • Publication number: 20150306097
    Abstract: Embodiments of a hydrazaline hydrochloride composition for treatment of hypoertension in humans each provide sustained release of hydralazine hydrochloride administered in the form of pellets, granules and tablets. Methods of preparation are disclosed.
    Type: Application
    Filed: February 12, 2015
    Publication date: October 29, 2015
    Inventor: Navaneeta K. Gorrepati
  • Publication number: 20100272793
    Abstract: The invention is for a method and composition for preparing a controlled release pharmaceutical formulation which can be used to administer Hydralazine hydrochloride over a 24 hours time frame, and for controlled release oral dosage forms of Hydralazine hydrochloride in the form of a tablet and a capsule.
    Type: Application
    Filed: April 22, 2009
    Publication date: October 28, 2010
    Inventor: Navaneeta K. Gorrepati